Press Release

Microbiology Testing Market to Grow with a CAGR of 6.41% through 2029

Increasing concerns about foodborne illnesses and increase in the growth of the food processing and manufacturing industry is expected to drive the India Microbiology Testing Market growth in the forecast period, 2024-2028.

 

According to TechSci Research report, “Microbiology Testing Market – India Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the India Microbiology Testing Market stood at USD 130.59 million in 2022 and is anticipated to grow with a CAGR of 6.41% in the forecast period, 2024-2028. The awareness among individuals regarding Microbiology Testing has led to favorable market conditions for the India Microbiology Testing market. Several factors contribute to the growth of various Microbiology Testing products.

The India Microbiology Testing Market is intricately linked to the country's escalating disease burden. Microbiology testing has emerged as a critical tool in disease management, offering early detection, monitoring of antibiotic resistance, and outbreak control. With ongoing advancements and investments, the market is poised for substantial growth, contributing to India's efforts to combat the rising health challenges it faces.

Food safety regulations in the India Microbiology Testing Market are comprehensive and stringent, overseen by the FSSAI and state food authorities. Microbiology testing plays a central role in ensuring compliance with these regulations, from pathogen detection to quality control. As India's food industry evolves, microbiology testing will remain critical in safeguarding public health and maintaining the integrity of the food supply chain, which will further fuel market growth.

In September 2023, BD India launched the BD FACSVerse™ Flow Cytometer, a new flow cytometer that is designed to be affordable and easy to use. The BD FACSVerse™ Flow Cytometer is ideal for use in a variety of settings, including hospitals, clinics, and research laboratories. It can be used for a wide range of applications, including the diagnosis and monitoring of blood cancers, infectious diseases, and autoimmune diseases.

Indian pharmaceutical industry has emerged as a global player over the years. Known for its cost-effective manufacturing capabilities and a strong focus on research and development, it has become a hub for pharmaceutical production. The industry encompasses the production of generic drugs, active pharmaceutical ingredients (APIs), and biosimilars, serving both domestic and international markets.

In today's fast-paced world, infectious diseases can rapidly spread and cause public health crises, microbiology testing is critical for diagnosing infections swiftly. Rapid identification of pathogens, such as bacteria, viruses, and fungi, enables healthcare providers to initiate appropriate treatments promptly, preventing the spread of diseases. Microbiology testing aids in antibiotic stewardship, a crucial practice in a world grappling with antibiotic resistance. By conducting antimicrobial susceptibility testing (AST), microbiologists help healthcare professionals choose the most effective antibiotics, avoiding the overuse of broad-spectrum antibiotics that contribute to resistance. In the fast-paced food industry, microbiology testing ensures that food products meet safety standards. It allows for the detection of harmful microorganisms like Salmonella and E. coli, preventing foodborne outbreaks and ensuring the safety of consumers. The pharmaceutical industry operates in a high-paced environment where product quality is paramount. Microbiology testing is indispensable for ensuring the sterility of drugs, assessing microbial contamination in raw materials, and verifying the quality of pharmaceutical products.

           

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "India Microbiology Testing Market.”

 

The pharmaceutical sector in India has seen remarkable growth, and microbiology testing has been integral to this success. As the industry continues to evolve, the synergy between pharmaceuticals and microbiology testing will play a pivotal role in shaping its future, ensuring that it continues to meet global healthcare needs.

In recent times, microbiology testing has led to the emergence of rapid diagnostic techniques. Molecular biology methods, such as polymerase chain reaction (PCR) and nucleic acid amplification tests (NAATs), enable the rapid identification of pathogens, including viruses and bacteria. This speed is particularly vital during outbreaks, such as the COVID-19 pandemic, where timely diagnosis is crucial for containment and treatment. Microbiology testing has contributed to the era of precision medicine by allowing healthcare providers to tailor treatments to individual patients. Genetic sequencing and microbial profiling help identify specific strains of pathogens and their antibiotic resistance profiles. This information guides the selection of targeted therapies, improving treatment outcomes and minimizing side effects. With the global concern of antibiotic resistance, microbiology testing has become central to antibiotic stewardship programs. Hospitals and healthcare facilities use microbiology testing to identify the causative pathogens of infections and determine their susceptibility to antibiotics. This ensures the appropriate and judicious use of antibiotics, helping to slow the development of resistance. However, the Regulatory Compliance and Stringency may hinder market growth. Moreover, challenges related to Technological Advancements and Infrastructure may pose obstacles to the Microbiology Testing market in the near future.

The India Microbiology Testing Market is segmented into test type, product, indication, application, end-user, regional distribution, and company.

Based on its test type, Bacterial testing is paramount in healthcare and clinical diagnostics. It includes the identification and characterization of bacterial pathogens responsible for various infectious diseases. Timely and accurate diagnosis of bacterial infections is critical for patient care, treatment decisions, and the prevention of outbreaks. Hospitals, diagnostic laboratories, and healthcare facilities heavily rely on bacterial testing to diagnose conditions such as urinary tract infections, respiratory tract infections, sepsis, and gastrointestinal infections. Additionally, antimicrobial susceptibility testing (AST) helps guide physicians in choosing the most effective antibiotics, especially in an era of rising antibiotic resistance. Bacterial infections are widespread in India, making up a significant portion of the country's disease burden. This prevalence drives the demand for bacterial testing, leading to the dominance of this segment within the microbiology testing market.

Based on region, West India segment is expected to grow during the forecast period.  Maharashtra, with its economic capital Mumbai, has historically been a key player in India's healthcare and pharmaceutical sectors. The state houses numerous hospitals, diagnostic centers, research institutions, and pharmaceutical companies, making it a significant hub for microbiology testing. The high population density, urbanization, and industrialization in Maharashtra contribute to a substantial demand for microbiology testing services. Hospitals and diagnostic centers in cities like Mumbai and Pune have well-established microbiology laboratories catering to diverse healthcare needs. Maharashtra is a major pharmaceutical manufacturing hub, and quality control and microbiology testing are integral to pharmaceutical production. The pharmaceutical sector's presence drives the demand for microbiology testing, particularly in drug manufacturing and quality assurance.

The South India market is poised to be the fastest-growing market, offering lucrative growth opportunities for Microbiology Testing Market players during the forecast period. Factors such as South Indian states have made substantial investments in healthcare infrastructure, including hospitals, diagnostic centers, and research institutions. This expansion leads to increased demand for microbiology testing services. South India has a growing pharmaceutical and biotechnology sector, with companies engaged in research, development, and manufacturing. This sector's growth drives the need for microbiology testing for quality control and research purposes. The region is home to renowned educational and research institutions, fostering collaborations in microbiology research. This contributes to the demand for advanced microbiology testing methodologies. South India attracts a significant number of medical tourists due to its world-class healthcare facilities. These facilities require state-of-the-art microbiology testing services, further boosting the market.

 

Major companies operating in India Microbiology Testing Market are:

  • Cepheid India Private Limited
  • BD India Private Limited
  • BIO-RAD LABORATORIES (INDIA) PRIVATE LIMITED.
  • Dr. Reddy's Laboratories Limited
  • Biocon Limited
  • Abbott India Limited
  • Beckman Coulter India Private Limited.
  • Agilent Technologies India Private Limited.
  • Neogen Chemicals Limited.
  • Thermo Fisher Scientific India Private Limited

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The need to assess and control microbial contamination and growing awareness of infectious diseases are key drivers of the Microbiology Testing market. In recent years, the growing ongoing research in biotechnology, pharmaceuticals, and biopharmaceuticals relies heavily on microbiology testing for product development and safety assessment. Moreover, the growing consumer emphasis on preventative healthcare products has enhanced production and marketing efforts. To meet the demands of the market, manufacturers are increasingly incorporating cutting-edge technologies with high production efficiency. Rising consumer acceptance and continuous product innovation will further ensure the growth of the Microbiology Testing and supplements market in the coming years.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

India Microbiology Testing Market Segmented By Type (Bacterial, Viral, Fungal), By Product (Instruments, Reagents), By Indication (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infection, Periodontal Diseases, Others), By Application (Pharmaceutical, Food Testing, Clinical, Energy, Chemical and Material Manufacturing, Environmental), By End-User (Hospitals and Diagnostic Centers, Custom Lab Service Providers, Academic, and Research Institutes), By Country, Competition, Forecast, Opportunities, 2019-2029F”, has evaluated the future growth potential of India Microbiology Testing Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Microbiology Testing Market.

 

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: www.techsciresearch.com

Relevant News